Literature DB >> 21835668

[Oocyte/embryo cryopreservation before chemotherapy for breast cancer].

C Decanter1, J Gligorov.   

Abstract

Breast cancer affects 6300 new patients per year under age 40 per year in France. The new adjuvant chemotherapy protocols have significantly improved the prognosis of these young women who may wish to conceive later. Embryo cryopreservation is the best way to preserve fertility, providing 25 to 35% chance of pregnancy. Oocyte freezing may be an alternative for single patients. This review will focus on: (1) ovarian toxicity of new adjuvant chemotherapy protocols, (2) the place of embryo or oocyte cryopreservation in fertility preservation techniques, (3) indications and protocols.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21835668     DOI: 10.1016/j.gyobfe.2011.07.011

Source DB:  PubMed          Journal:  Gynecol Obstet Fertil        ISSN: 1297-9589


  2 in total

Review 1.  Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis.

Authors:  Chuan Wang; Minyan Chen; Fangmeng Fu; Meng Huang
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

Review 2.  Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation.

Authors:  Marie-Christine Vantyghem; Jérôme Cornillon; Christine Decanter; Frédérique Defrance; Wassila Karrouz; Clara Leroy; Kristell Le Mapihan; Marie-Anne Couturier; Eva De Berranger; Eric Hermet; Natacha Maillard; Ambroise Marcais; Sylvie Francois; Reza Tabrizi; Ibrahim Yakoub-Agha
Journal:  Orphanet J Rare Dis       Date:  2014-10-29       Impact factor: 4.123

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.